Concentration of cefuroxime in middle ear effusion of children with acute otitis media

Pediatric Infectious Disease Journal

Volumn 16, Issue 10, 1997, Pages 959-962

  Thoroddsen, Einar ^a   Marr, Clara ^b   Efthymiopoulos, Constantin ^b   Thorarinsson, Hjorleifur ^c  

^a Medical Clinic   (Iceland)

^b GLAXOSMITHKLINE   (United Kingdom)

^c Glaxo Wellcome Iceland   (Iceland)

Author keywords

Acute otitis media; Cefuroxime; Cefuroxime axetil; Middle ear effusion; Serum; Time above minimum inhibitory concentration

Indexed keywords

CEFUROXIME AXETIL;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM IDENTIFICATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG PENETRATION; HAEMOPHILUS INFLUENZAE; HUMAN; MIDDLE EAR EFFUSION; MORAXELLA CATARRHALIS; MYRINGOTOMY; ORAL DRUG ADMINISTRATION; OTITIS MEDIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS PNEUMONIAE;

ACUTE DISEASE; ADMINISTRATION, ORAL; CEFUROXIME; CEPHALOSPORINS; CHILD, PRESCHOOL; HUMANS; INFANT; MICROBIAL SENSITIVITY TESTS; OTITIS MEDIA WITH EFFUSION;

EID: 0030773373     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199710000-00011     Document Type: Article

References (14)

1. Jorgensen JH, Doern GV, Maher LA, Howell AW, Redding JS. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother 1990;34:2075-80.
2. Doern GV, Vautour R, Parker D, Tubert T, Torres B. In vitro activity of loracarbef (LY163892), a new oral carbacephem antimicrobial agent, against respiratory isolates of Haemophilus influenzae and Moraxella catarrhalis. Antimicrob Agents Chemother 1991;35:1504-7.
3. Harding SM, Williams PO, Ayrton J. Pharmacology of cefuroxime as the 1-acetoxyethyl ester in volunteers. Antimicrob Agents Chemother 1984;25:78-82.
4. Wise R, Bennett SA, Dent J. The pharmacokinetics of orally absorbed cefuroxime compared with amoxycilin/clavulanic acid. J Antimicrob Chemother 1984;13:603-10.
5. McLinn SE, Moskal M, Goldfarb J, et al. Comparison of cefuroxime axetil and amoxicillin-clavulanate suspensions in treatment of acute otitis media with effusion in children. Antimicrob Agents Chemother 1994;38:315-8.
6. Gooch WM 3rd, Blair E, Puopolo A, et al. Clinical comparison of cefuroxime axetil suspension and amoxicillin/clavulanate suspension in the treatment of pediatric patients with acute otitis media with effusion. Clin Ther 1995;17:838-51.
7. Haddad J Jr, Isaacson G, Respler DS, et al. Concentration of cefuroxime in serum and middle ear effusion after single dose treatment with cefuroxime axetil. Pediatr Infect Dis J 1991; 10:294-8.
8. Craig WA. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad spectrum cephalosporins. Diagn Microbiol Infect Dis 1995;22:89-96.
9. Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J 1996;15: 255-9.
10. Jossart GH, Canafax DM, Erdmann GR, et al. Effect of Streptococcus pneumoniae and influenza A virus on middle ear antimicrobial pharmacokinetics in experimental otitis media. Pharm Res 1994;11:860-4.
11. Canafax DM. Factors affecting middle ear antibiotic penetration. In: International clinical practice series: otitis media: prospects for management. Kent, UK: Wells Medical Ltd., 1996:15-20.
12. Juhn SK, Edlin J, Jung TTK, Giebink SB. The kinetics of penicillin diffusion in serum and middle ear effusions in experimentally induced otitis media. Arch Otorhinolaryngol 1986;243:183-5.
13. Powell DA, James NC, Ossi MJ, Nahata MC, Donn KH. Pharmacokinetics of cefuroxime axetil suspension in infants and children. Antimicrob Agents Chemother 1991;35:2042-5.
14. Spangler SK, Jacobs MR, Applebaum PC. In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime and cefdinir. Antimicrob Agents Chemother 1994;38:2902-4.